HealthEquity, Inc.

HQY Healthcare Health Information Services

HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

92.03 0.48 −0.52%
Market cap
$7.7B
P/E
33.0×
Fwd P/E
30.2×
Dividend yield
—
F-score
9/9
Altman Z
4.39
Beneish M
−2.77
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jan '17 Jan '18 Jan '19 Jan '20 Jan '21 Jan '22 Jan '23 Jan '24 Jan '25 Jan '26
Net Income
26.38 47.36 73.90 39.66 8.83 (44.29) (26.14) 55.71 96.70 215.20
Depreciation & Amortization
13.19 15.95 18.25 58.06 121.01 141.64 164.46 155.93 164.52 155.72
Non Cash Items (Other)
5.64 19.21 22.24 16.67 39.48 42.02 45.70 64.31 85.17 112.79
Accounts Receivable Change
(2.73) (4.73) (4.07) (4.03) (0.41) (11.20) (9.57) (8.06) (13.11) (5.69)
Accounts Payable Change
0.57 (0.58) 3.89 1.92 30.42 (2.18) (26.67) (0.20) 8.89 1.71
Change in payables and accrued liability
2.68 4.31 4.43 4.55 0.77 (3.66) (1.28) 2.95 17.76 (8.81)
Change in other assets and liabilities
(0.12) 0.18 (5.23) (11.82) (18.48) 18.66 4.16 (27.82) (20.06) (13.83)
Operating Cash Flow
45.59 81.70 113.42 105.01 181.62 141.00 150.65 242.83 339.86 457.09
Capital expenditures
(12.67) (15.84) (13.85) (32.94) (64.59) (71.62) (48.54) (42.82) (53.21) (48.48)
Change in intangibles (net)
— (17.54) (1.19) (9.13) (32.37) (65.46) (70.58) (3.26) (452.24) (0.29)
Net Aquisitions
— (2.88) — (1,644.57) — (504.53) — — — —
Short Term Investments Change (Net)
(0.38) (0.48) 40.69 (53.84) 0.00 2.37 0.00 0.00 — —
Other investing activities
16.63 (10.38) (9.98) (215.79) (3.86) (6.49) (0.60) — — 1.64
Investing cash flow
(13.05) (36.75) 25.65 (1,740.49) (96.96) (639.25) (119.13) (46.07) (505.45) (47.14)
Repayment/Issuance of Debt (Net)
— — — 1,242.19 (239.06) (53.12) (8.75) (54.37) 175.00 (100.00)
Equity Repurchase (Common, Net)
7.14 14.56 22.93 469.84 295.35 466.39 6.68 6.47 (112.06) (287.84)
Other financial activities
16.63 14.91 22.23 (246.29) (3.86) (18.41) (0.60) 0.87 (5.37) 0.87
Financing cash flow
23.78 14.56 22.93 1,465.74 52.42 394.86 (2.67) (47.04) 57.57 (386.97)
Change in Cash
56.31 59.52 162.00 (169.75) 137.08 (103.39) 28.85 149.71 (108.03) 22.98
Beginning Cash
83.64 139.95 199.47 361.48 191.73 328.80 225.41 254.27 403.98 295.95
Ending Cash
139.95 199.47 361.48 191.73 328.80 225.41 254.27 403.98 295.95 318.93
Stock Based Compensation
8.40 14.31 21.06 39.84 42.86 52.75 62.61 77.15 96.43 73.06
Dividends Paid (Common)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
0.39 (0.82) (0.97) (9.38) 12.30 1.63 (33.37) (33.13) (6.53) (26.62)
Investments Change (Net)
(0.38) (0.48) 40.69 (53.84) — 2.37 — — — —
Issuance/Purchase of Shares
7.14 14.56 22.93 469.84 295.35 466.39 6.68 6.47 (112.06) (287.84)
Other line items
Revenue per Employee
0.20 0.22 0.25 0.18 0.24 0.20 0.27 0.32 0.38 0.47

Fold the line items

In millions of $ except per-share values · columns are period end dates